Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Lepr(db)/+Lepr(db) Mice

Obesity and related metabolic disorders, such as diabetes mellitus, raise the risk of liver carcinogenesis. Metformin, which is widely used in the treatment of diabetes, ameliorates insulin sensitivity. Metformin is also thought to have antineoplastic activities and to reduce cancer risk. The presen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Ohno, Tomohiko, Shimizu, Masahito, Shirakami, Yohei, Baba, Atsushi, Kochi, Takahiro, Kubota, Masaya, Tsurumi, Hisashi, Tanaka, Takuji, Moriwaki, Hisataka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399835/
https://ncbi.nlm.nih.gov/pubmed/25879666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0124081
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak